Kathryn Sowerwine
NPI: 1477712867
Total Payments
$833,607
2024 Payments
$104,052
Companies
43
Transactions
1,591
Medicare Patients
965
Medicare Billing
$85,059
Payment Breakdown by Category
Other$617,581 (74.1%)
Travel$103,130 (12.4%)
Consulting$83,026 (10.0%)
Food & Beverage$28,588 (3.4%)
Research$1,200 (0.1%)
Education$81.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $617,581 | 245 | 74.1% |
| Travel and Lodging | $103,130 | 376 | 12.4% |
| Consulting Fee | $83,026 | 45 | 10.0% |
| Food and Beverage | $28,588 | 922 | 3.4% |
| Unspecified | $1,200 | 1 | 0.1% |
| Education | $81.73 | 2 | 0.0% |
Payments by Type
General
$832,407
1,590 transactions
Research
$1,200
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $377,291 | 424 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $351,442 | 561 | $0 (2024) |
| ABBVIE INC. | $38,568 | 136 | $0 (2024) |
| PFIZER INC. | $23,736 | 107 | $0 (2024) |
| Dermavant Sciences, Inc. | $11,759 | 20 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $9,896 | 19 | $0 (2024) |
| Lilly USA, LLC | $8,373 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,562 | 25 | $0 (2024) |
| UCB, Inc. | $1,537 | 15 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $501.79 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104,052 | 193 | GENZYME CORPORATION ($65,901) |
| 2023 | $79,057 | 172 | GENZYME CORPORATION ($56,637) |
| 2022 | $121,043 | 241 | GENZYME CORPORATION ($51,778) |
| 2021 | $50,891 | 136 | GENZYME CORPORATION ($23,908) |
| 2020 | $44,873 | 112 | Regeneron Healthcare Solutions, Inc. ($21,121) |
| 2019 | $208,696 | 300 | Regeneron Healthcare Solutions, Inc. ($123,171) |
| 2018 | $168,063 | 286 | Regeneron Healthcare Solutions, Inc. ($89,729) |
| 2017 | $56,932 | 151 | Regeneron Healthcare Solutions, Inc. ($29,809) |
All Payment Transactions
1,591 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,128.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $13.03 | General |
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.33 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.77 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,458.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $147.48 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $32.83 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $4,510.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $450.95 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $282.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | In-kind items and services | $220.54 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Food and Beverage | In-kind items and services | $134.71 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Food and Beverage | In-kind items and services | $73.62 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Travel and Lodging | Cash or cash equivalent | $64.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Food and Beverage | In-kind items and services | $46.86 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Food and Beverage | In-kind items and services | $41.76 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 278 | 391 | $46,448 | $25,337 |
| 2022 | 8 | 223 | 342 | $36,217 | $21,795 |
| 2021 | 8 | 205 | 309 | $31,471 | $20,428 |
| 2020 | 9 | 259 | 380 | $33,074 | $17,500 |
Total Patients
965
Total Services
1,422
Medicare Billing
$85,059
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 90 | $15,750 | $8,607 | 54.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 34 | 42 | $6,426 | $4,271 | 66.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 43 | $5,375 | $3,068 | 57.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 46 | 63 | $6,993 | $3,016 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $5,675 | $2,850 | 50.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,150 | $1,535 | 48.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 21 | 21 | $2,100 | $1,443 | 68.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 29 | 89 | $979.00 | $546.36 | 55.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 66 | $10,362 | $6,777 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 52 | $5,771 | $3,827 | 66.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 24 | 29 | $4,437 | $2,727 | 61.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $4,333 | $2,291 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,859 | $2,142 | 55.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 26 | 26 | $2,480 | $1,826 | 73.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 30 | 36 | $3,996 | $1,671 | 41.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 17 | 89 | $979.00 | $535.06 | 54.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 73 | $10,804 | $7,924 | 73.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 45 | $4,410 | $3,121 | 70.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,405 | $2,286 | 67.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 25 | 28 | $2,520 | $1,872 | 74.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 26 | 37 | $4,107 | $1,704 | 41.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 18 | 18 | $2,754 | $1,685 | 61.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $2,646 | $1,391 | 52.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 17 | 75 | $825.00 | $444.62 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 91 | $8,918 | $5,309 | 59.5% |
About Kathryn Sowerwine
Kathryn Sowerwine is a Student in an Organized Health Care Education/Training Program healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477712867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathryn Sowerwine has received a total of $833,607 in payments from pharmaceutical and medical device companies, with $104,052 received in 2024. These payments were reported across 1,591 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($617,581).
As a Medicare-enrolled provider, Sowerwine has provided services to 965 Medicare beneficiaries, totaling 1,422 services with total Medicare billing of $85,059. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Washington, DC
- Active Since 06/02/2008
- Last Updated 08/11/2009
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1477712867
Products in Payments
- DUPIXENT (Biological) $420,586
- DUPIXENT (Drug) $143,058
- DUPIXENT DUPILUMAB INJECTION (Biological) $119,538
- RINVOQ (Biological) $29,515
- ATOPIC DERMATITIS - DISEASE (Drug) $25,220
- EUCRISA (Drug) $20,681
- TAPINAROF (Drug) $9,960
- Zoryve (Drug) $4,585
- RINVOQ (Drug) $2,800
- CIBINQO (Drug) $1,864
- VTAMA (Drug) $1,799
- HUMIRA (Biological) $1,477
- SKYRIZI (Biological) $950.83
- TALTZ (Drug) $876.28
- Humira (Biological) $418.80
- Sotyktu (Drug) $417.72
- COSENTYX (Biological) $251.35
- OPZELURA (Drug) $243.77
- Bimzelx (Biological) $240.44
- ARAZLO (Drug) $236.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Washington
Brian Barry, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $332,321
Student in an Organized Health Care Education/Training Program $332,321
Dr. Benjamin Weinberg, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $283,071
Student in an Organized Health Care Education/Training Program $283,071
Joshua Reuss, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $180,362
Student in an Organized Health Care Education/Training Program $180,362
Chul Kim
Student in an Organized Health Care Education/Training Program — Payments: $109,637
Student in an Organized Health Care Education/Training Program $109,637
Dr. Yana Najjar, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $97,869
Student in an Organized Health Care Education/Training Program $97,869
Dr. Ashley Broussard, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $96,211
Student in an Organized Health Care Education/Training Program $96,211